XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $664 | +22.3% | 18,562 | +34.9% | 0.07% | -1.5% |
| Q4 2022 | $543 | -99.4% | 13,763 | +2.8% | 0.07% | +1016.7% |
| Q1 2016 | $94,000 | -69.1% | 13,384 | -64.6% | 0.01% | -60.0% |
| Q4 2015 | $304,000 | -44.2% | 37,791 | -42.7% | 0.02% | -44.4% |
| Q3 2015 | $545,000 | +42.3% | 65,941 | +98.4% | 0.03% | +80.0% |
| Q2 2015 | $383,000 | +85.0% | 33,244 | +170.3% | 0.02% | +87.5% |
| Q1 2015 | $207,000 | – | 12,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |